InvestorsHub Logo
Followers 484
Posts 60886
Boards Moderated 18
Alias Born 09/20/2001

Re: Joseph_K post# 455267

Thursday, 03/28/2024 6:23:31 PM

Thursday, March 28, 2024 6:23:31 PM

Post# of 462472
... AVXL staff would likely have discussed these changes with the FDA per the timing. They would have agreed that a decision not be rushed until this issue was resolved. In the mean time they continued to treat and continued to collect data...


Neurodegeneration and cognitive decline slow with Anavex 2-73
Benefits include slower rate of brain shrinkage, amyloid-beta protein reductions

Lindsey Shapiro, PhD avatar
by Lindsey Shapiro, PhD | September 15, 2023


https://alzheimersnewstoday.com/news/early-alzheimers-anavex-2-73-slows-cognitive-decline-neurodegeneration/#:~:text=The%20treatment%20also%20was%20associated,or%20more%20%E2%80%94%20over%20a%20placebo.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News